Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae, Functional specialization of interleukin-17 family members, Immunity, vol.34, pp.149-62, 2011.

D. J. Cua and C. M. Tato, Innate IL-17-producing cells: the sentinels of the immune system, Nat Rev Immunol, vol.10, pp.479-89, 2010.

J. C. Ribot, A. Debarros, and D. J. Pang, CD27 is a thymic determinant of the balance between interferon-gammaand interleukin 17-producing gammadelta T cell subsets, Nat Immunol, vol.10, pp.427-463, 2009.

A. V. Rachitskaya, A. M. Hansen, and R. Horai, Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion, J Immunol, vol.180, pp.5167-71, 2008.

A. D. Pandya, Z. Al-jaderi, and R. A. Hoglund, Identification of human NK17/NK1 cells, PLoS One, vol.6, p.26780, 2011.

A. J. Hueber, D. L. Asquith, and A. M. Miller, Mast cells express IL-17A in rheumatoid arthritis synovium, J Immunol, vol.184, pp.3336-3376, 2010.

X. Zhu, L. A. Mulcahy, and R. A. Mohammed, IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines, Breast Cancer Res, vol.10, p.95, 2008.

Z. Tan, X. Qian, and R. Jiang, IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation, J Immunol, vol.191, pp.1835-1879, 2013.

P. R. Taylor, S. Roy, S. M. Leal, and . Jr, Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2, Nat Immunol, vol.15, pp.143-51, 2014.

A. Gladiator, N. Wangler, K. Trautwein-weidner, and S. Leibundgut-landmann, Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection, J Immunol, vol.190, pp.521-526, 2013.

F. Lafdil, A. M. Miller, S. H. Ki, and B. Gao, Th17 cells and their associated cytokines in liver diseases, Cell Mol Immunol, vol.7, pp.250-254, 2010.

R. Liao, J. Sun, and H. Wu, High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma, J Exp Clin Cancer Res, vol.32, p.3, 2013.

F. M. Gu, Q. L. Li, and Q. Gao, IL-17 induces AKTdependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma, Mol Cancer, vol.10, p.150, 2011.

W. J. Du, J. H. Zhen, and Z. Q. Zeng, Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection, Diagn Pathol, vol.8, p.40, 2013.

J. Y. Zhang, Z. Zhang, and F. Lin, Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B, Hepatology, vol.51, pp.81-91, 2010.

F. Meng, K. Wang, and T. Aoyama, Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice, Gastroenterology, vol.143, pp.1-3, 2012.

E. Fugier, H. Marche, and M. A. Thelu, Functions of liver natural killer cells are dependent on the severity of liver inflammation and fibrosis in chronic hepatitis C, PLoS One, vol.9, p.95614, 2014.

E. Jouvin-marche, M. Jilkova, Z. Thelu, and M. A. , Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels, J Infect Dis, vol.209, pp.1907-1922, 2014.

M. Ramzan, N. Sturm, and T. Decaens, Liver-infiltrating CD8+ lymphocytes as prognostic factor for tumor recurrence in hepatitis C virus-related hepatocellular carcinoma, Liver Int, vol.36, pp.434-478, 2016.

J. Pillay, T. Tak, V. M. Kamp, and L. Koenderman, Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences, Cell Mol Life Sci, vol.70, pp.3813-3840, 2013.

L. Li, L. Huang, and A. L. Vergis, IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury, J Clin Investig, vol.120, pp.331-373, 2010.

R. Rao, C. S. Graffeo, and R. Gulati, Interleukin 17-producing gamma delta T cells promote hepatic regeneration in mice, Gastroenterology, vol.147, pp.473-84, 2014.

R. G. Foster, L. Golden-mason, A. Rutebemberwa, and H. R. Rosen, Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection, Dig Dis Sci, vol.57, pp.381-390, 2012.

D. J. Farrell, J. E. Hines, and A. F. Walls, Intrahepatic mast cells in chronic liver diseases, Hepatology, vol.22, pp.1175-81, 1995.

R. Xu, H. Huang, Z. Zhang, and F. S. Wang, The role of neutrophils in the development of liver diseases, Cell Mol Immunol, vol.11, pp.224-255, 2014.

Z. Qi, X. Wang, H. Wei, R. Sun, and Z. Tian, Infiltrating neutrophils aggravate metabolic liver failure in FAH-deficient mice, Liver Int, vol.35, pp.774-85, 2015.

P. Kruger, M. Saffarzadeh, and A. N. Weber, Neutrophils: between host defence, immune modulation, and tissue injury, PLoS Pathog, vol.11, p.1004651, 2015.

C. L. Wilson, D. Jurk, and N. Fullard, NFkappaB1 is a suppressor of neutrophil-driven hepatocellular carcinoma, Nat Commun, vol.6, p.6818, 2015.

I. B. Mcinnes, P. J. Mease, and B. Kirkham, Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet, vol.386, pp.1137-1183, 2015.

H. Qi, H. Yang, and G. Xu, Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice, Immunobiology, vol.220, pp.54-63, 2015.

L. D. Roy, M. Sahraei, and J. L. Schettini, Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/ SDF-1 expression in the metastatic niches, BMC Cancer, vol.14, p.225, 2014.